Literature DB >> 6431362

Craniocervical necrotizing fasciitis.

E M Spankus, P W Flint, R J Smith, R H Miller.   

Abstract

Craniocervical necrotizing fasciitis (CCNF) is a severe, progressive bacterial infection of the cervical fascia. The most significant manifestations of this disease are extensive fascial necrosis with widespread undermining of the surrounding tissues and extreme systemic toxicity. We are adding three cases to the 29 previously reported cases of CCNF. We will discuss the regional anatomy, focusing on the relationship of the cervical fascial planes to vital structures. Available data suggest that CCNF is a synergistic infection produced in most instances by a combination of facultative anaerobic and obligate anaerobic organisms. Although antimicrobial therapy should provide broad-spectrum activity against mixed flora, treatment also includes aggressive excision and debridement of involved fascia, subcutaneous tissue, and necrotic skin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6431362     DOI: 10.1177/019459988409200303

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  4 in total

1.  Management of facial necrotizing fasciitis.

Authors:  Christian Schurr; M Burghartz; T Miethke; M Kesting; N Hoang; R Staudenmaier
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-11-29       Impact factor: 2.503

2.  Does diclofenac increase the risk of cervical necrotizing fasciitis in a rat model?

Authors:  Elie G Eter; Aline Khazzaka; Wadad Mneimneh; Dolla Karam-Sarkis; Amine Haddad; Riad Sarkis
Journal:  Int J Exp Pathol       Date:  2009-02       Impact factor: 1.925

3.  Mediastinitis following deep neck infections : A therapeutic challenge.

Authors:  N K Panda; S B Mann; S C Sharma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2000-10

4.  Laboratory Risk Indicator for Necrotizing Fasciitis of the Oro-Cervical Region (LRINEC-OC): A Possible Diagnostic Tool for Emergencies of the Oro-Cervical Region.

Authors:  Masaru Ogawa; Satoshi Yokoo; Yu Takayama; Jun Kurihara; Takaya Makiguchi; Takahiro Shimizu
Journal:  Emerg Med Int       Date:  2019-11-14       Impact factor: 1.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.